Changsatja S, Kositamongkol C, Thamlikitkul L, Phisalprapa P, Komonpaisarn T.
. Cost-Utility Analysis of Adjuvant Osimertinib in Resected Epidermal-Growth-Factor-Receptor-Mutated Early-Stage Non-Small Cell Lung Cancer
. Value Health Reg Issues.
2025.
54
Department : Medicine
Journal Name : Value Health Reg Issues Source : Pubmed